Mohamed, F.E.; Alzyoud, L.; Ghattas, M.A.; Tabouni, M.; Fienemann, A.; Trinh, J.; Baydoun, I.; Kizhakkedath, P.; Alblooshi, H.; Shaukat, Q.;
et al. Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase. Int. J. Mol. Sci. 2025, 26, 3056.
https://doi.org/10.3390/ijms26073056
AMA Style
Mohamed FE, Alzyoud L, Ghattas MA, Tabouni M, Fienemann A, Trinh J, Baydoun I, Kizhakkedath P, Alblooshi H, Shaukat Q,
et al. Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase. International Journal of Molecular Sciences. 2025; 26(7):3056.
https://doi.org/10.3390/ijms26073056
Chicago/Turabian Style
Mohamed, Feda E., Lara Alzyoud, Mohammad A. Ghattas, Mohammed Tabouni, André Fienemann, Joanne Trinh, Ibrahim Baydoun, Praseetha Kizhakkedath, Hiba Alblooshi, Qudsia Shaukat,
and et al. 2025. "Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase" International Journal of Molecular Sciences 26, no. 7: 3056.
https://doi.org/10.3390/ijms26073056
APA Style
Mohamed, F. E., Alzyoud, L., Ghattas, M. A., Tabouni, M., Fienemann, A., Trinh, J., Baydoun, I., Kizhakkedath, P., Alblooshi, H., Shaukat, Q., Amouri, R., Farrer, M. J., Sassi, S. B., & Al-Jasmi, F.
(2025). Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase. International Journal of Molecular Sciences, 26(7), 3056.
https://doi.org/10.3390/ijms26073056
